Medical Necessity and Experimental and Investigational - Medical Policy
Customize your policy alerts
Sign up for Health-New-England Policy UM407POL alerts
Get alerted when Policy UM407POL changes without checking for updates manually.
Monitor payer policy activity
This policy defines how Health New England evaluates medical necessity, lack of medical necessity, and experimental or investigational status for healthcare services, procedures, technologies, devices, biologics, and drug therapies. It applies to Commercial, Medicare Advantage, and Medicaid (BeHealthy) lines of business and supports prior-authorization review.
The experimental and investigational definition was revised in June 2025.
The Medicaid definition of medical necessity was updated in 2025.
InterQual CP: Procedures criteria were added to the experimental and investigational policy guidelines in June 2025.
Minor updates were made to the policy guidelines in May 2026.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.